Formulations of Natural Origin and Synthetic Derivatives for the Treatment of Multi-Resistant Microorganisms
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: closed (10 February 2022) | Viewed by 3830
Special Issue Editors
Interests: pharmaceutical analysis; natural products; electrospinning; electrospraying; biopolymers; coaxial; controlled drug delivery; nanofiber; polymer therapeutics; sustained release; tissue engineering; wound healing; biodegradable; gene therapy; polycaprolactone; drug metabolism and phytochemistry
Special Issues, Collections and Topics in MDPI journals
Interests: chalcones; nanoemulsions; antimicrobials; anticancer
Special Issue Information
Dear Colleagues,
Drug resistance by multidrug-resistant microorganisms (bacteria and fungi) is one of the priority problems for the World Health Organization, since they constitute a dilemma throughout the world due to their rapid dissemination, as well as the difficulty of their treatment. At present, there is a global trend towards a reduction in the use of current drugs that generate resistance, and, in their replacement, natural substances of low toxicity have been chosen. In this sense, phytopharmaceuticals based on natural products are shown to be an economically and socially viable alternative. Although there are many advantages in the use of natural products as new drugs, there are some problems that need to be solved. Indeed, nanotechnological applications for the control of multi-resistant microorganisms, such as nanoformulations, are one of the most novel and growing fields of research with the potential to solve these problems. This Special Issue aims to compile cutting-edge research and review papers illustrating the potential of extracts and active principles obtained from plants, as well as their derivatives, against multidrug-resistant microorganisms, with a special focus on new delivery systems. In addition, this issue will focus particularly on aspects of design, development, manufacturing, characterization and modeling of formulations for pharmaceutical application.
Dr. Ian S. Blagbrough
Dr. Alejandro Martín Madrid Villegas
Dr. Iván Jose Montenegro Venegas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug design
- natural products
- biopharmaceutics
- nanoemulsion
- nanotechnology
- botanical drug
- phytonanotechnology
- nanopharmacology
- drug targeting
- molecular biology
